- Home
- MRUS vs RXRX Comparison
MRUS vs RXRX Comparison
Compare MRUS & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- RXRX
- Stock Information
- Founded
- MRUS 2003
- RXRX 2013
- Country
- MRUS Netherlands
- RXRX United States
- Employees
- MRUS N/A
- RXRX N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MRUS Health Care
- RXRX Health Care
- Exchange
- MRUS Nasdaq
- RXRX Nasdaq
- Market Cap
- MRUS 2.9B
- RXRX 2.6B
- IPO Year
- MRUS 2016
- RXRX 2021
- Fundamental
- Price
- MRUS $43.92
- RXRX $6.90
- Analyst Decision
- MRUS Strong Buy
- RXRX Buy
- Analyst Count
- MRUS 12
- RXRX 5
- Target Price
- MRUS $87.92
- RXRX $9.25
- AVG Volume (30 Days)
- MRUS 635.1K
- RXRX 15.4M
- Earning Date
- MRUS 10-31-2024
- RXRX 11-06-2024
- Dividend Yield
- MRUS N/A
- RXRX N/A
- EPS Growth
- MRUS N/A
- RXRX N/A
- EPS
- MRUS N/A
- RXRX N/A
- Revenue
- MRUS $35,932,000.00
- RXRX $65,184,000.00
- Revenue This Year
- MRUS N/A
- RXRX $60.17
- Revenue Next Year
- MRUS $57.37
- RXRX $19.88
- P/E Ratio
- MRUS N/A
- RXRX N/A
- Revenue Growth
- MRUS N/A
- RXRX 37.64
- 52 Week Low
- MRUS $24.95
- RXRX $5.60
- 52 Week High
- MRUS $61.61
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- MRUS 43.33
- RXRX 49.29
- Support Level
- MRUS $41.03
- RXRX $6.75
- Resistance Level
- MRUS $43.68
- RXRX $7.85
- Average True Range (ATR)
- MRUS 2.28
- RXRX 0.73
- MACD
- MRUS 0.14
- RXRX -0.02
- Stochastic Oscillator
- MRUS 29.61
- RXRX 15.43
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.